Methyiphenidate vs. amphetamine: Comparative review
Open accessAbstract
This article compares the two most common medications for Attention-Deficit/Hyperactivity Disorder (ADHD), using data from controlled studies. Medline and Psychinfo searches were done for 1984-1996 with the key words methylphenidate (MPH) and amphetamine (AMP); these were supplemented with known prior and recent literature. Of 92 animal studies found, 15 showed clear differences between the two drugs. Ten reports of controlled crossover ADHD clinical trials (three in the same sample) and a dozen other articles comparing the two drugs in humans were found. MPH is a pure re-uptake inhibitor of catecholamines, especially dopamine; AMP also releases catecholamines. Lab animals showed differential interactions with other drugs and with behavioral paradigms. Human response profiles are noncongruent. An ADHD patient who fails on one stimulant should try the other. Of 174 patients in the 6 clearest crossover studies, 48 responded better to AMP, 27 to MPH, and at least 72 to both, which is an 87+% overall response rate if both are tried. All crossovers, except the one with comorbid Tourette's, showed a nonsignificant tendency for AMP superiority in response rate. Summed data suggest suspected differences in side effects (AMP more sleep and appetite loss and exacerbation of tics in comorbid Tourette's, MPH possibly more depression/apathy and stomachaches) and effects on comorbid disorders (AMP better for conduct/oppositional symptoms, MPH for Tourette's and possibly learning disorder (LD). Most of the clinical differences are tendencies rather than statistically significant.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Although methylphenidate and amphetamine can effectively manage ADHD symptoms in most pediatric patients, many patients still fail to respond optimally to either.
“Although MPH and amphetamine can effectively manage ADHD symptoms in most pediatric patients, many patients still fail to respond optimally to either.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703 · see citing works
Ramabhadran, T. V. (1994) · CRC Press eBooks · doi:10.1201/b12597-9 · Cited by 787 · see citing works
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 535 · see citing works
Zetterström, T., Sharp, T., Collin, A.-K., & Ungerstedt, U. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90110-0 · Cited by 378 · see citing works
Rueckl, A. E., Gross, M. D., & Wilson, W. C. (1975) · AJN American Journal of Nursing · doi:10.2307/3423638 · Cited by 296 · see citing works
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294 · see citing works
Pelham, W. E., Greenslade, K. E., Vodde‐Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthrie, K. J., Hoover, M. D., & Dahl, R. E. (1990) · PEDIATRICS · doi:10.1542/peds.86.2.226 · Cited by 249 · see citing works
Castellanos, F. X., Giedd, J. N., Elia, J., Marsh, W., Ritchie, G. F., Hamburger, S. D., & Rapoport, J. L. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199705000-00008 · Cited by 239 · see citing works
Analog Classroom Assessment of Adderall® in Children With ADHD
SWANSON, J. M., WIGAL, S., GREENHILL, L. L., BROWNE, R., WASLIK, B., LERNER, M., WILLIAMS, L., FLYNN, D., AGLER, D., CROWLEY, K., et al. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199805000-00014 · Cited by 218 · see citing works
Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., Onyango, A. N., Forehand, G. L., Nguyen, A. H., & Waxmonsky, J. G. (1999) · PEDIATRICS · doi:10.1542/peds.103.4.e43 · Cited by 198 · see citing works
Mouse Model of Hyperkinesis Implicates SNAP-25 in Behavioral Regulation
Hess, E. J., Collins, K. A., & Wilson, M. C. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-09-03104.1996 · Cited by 184 · see citing works
Wall, S. C., Gu, H., & Rudnick, G. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08574-8 · Cited by 183 · see citing works
Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents
(1993) · Springer eBooks · doi:10.1007/978-1-4615-2884-5 · Cited by 164 · see citing works
In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis
Nomikos, G. G., Damsma, G., Wenkstern, D., & Fibiger, H. C. (1990) · Synapse · doi:10.1002/syn.890060113 · Cited by 157 · see citing works
BENZEDRINE® AND DEXEDRINE® IN THE TREATMENT OF CHILDREN'S BEHAVIOR DISORDERS
Bradley, C. (1950) · PEDIATRICS · doi:10.1542/peds.5.1.24 · Cited by 157 · see citing works
Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability?
Borcherding, B. G., Keysor, C. S., Rapoport, J. L., Elia, J., & Amass, J. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90151-t · Cited by 150 · see citing works
Mithani, S., Martin-Iverson, M. T., Phillips, A. G., & Fibiger, H. C. (1986) · Psychopharmacology · doi:10.1007/bf00181251 · Cited by 145 · see citing works
Svensson, K. A., Johansson, A. M., Magnusson, T., et al. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508777 · Cited by 133 · see citing works
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.5.658 · Cited by 129 · see citing works
Arnold, L. E. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280073008 · Cited by 104 · see citing works
Self-citationManos, M. J., Short, E. J., & Findling, R. L. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00010 · Cited by 103 · see citing works
ADHD in Girls: Clinical Comparability of a Research Sample
Sharp, W. S., WALTER, J. M., Marsh, W., Ritchie, G. F., HAMBURGER, S. D., & Castellanos, F. X. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199901000-00018 · Cited by 102 · see citing works
Ck, C. (1972) · PubMed · Cited by 93 · see citing works
Millichap, J. G., & Fowler, G. W. (1967) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)32054-5 · Cited by 92 · see citing works
ADHD in Girls: Clinical Comparability of a Research Sample
Sharp, W. S., Walter, J. M., Marsh, W., Ritchie, G. F., Hamburger, S. D., & Castellanos, F. X. (2002) · Routledge eBooks · doi:10.4324/9780203449523-12 · Cited by 91 · see citing works
Discriminative stimulus effects ofd-amphetamine, methylphenidate, and diazepam in humans
Heishman, S. J., & Henningfield, J. E. (1991) · Psychopharmacology · doi:10.1007/bf02244241 · Cited by 84 · see citing works
Stimulant drug treatment of hyperactivity: Biochemical correlates
Elia, J., Borcherding, B. G., Potter, W. Z., Mefford, I. N., Rapoport, J. L., & Keysor, C. S. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.118 · Cited by 83 · see citing works
(1987) · Pavlovian Journal of Biological Science · doi:10.1007/bf02700422 · Cited by 83 · see citing works
SYMPOSIUM: BEHAVIOR MODIFICATION BY DRUGS
Conners, C. K. (1972) · PEDIATRICS · doi:10.1542/peds.49.5.702 · Cited by 83 · see citing works
Weiss, G., MINDE, K. K., Douglas, V. I., WERRY, J. S., & Sykes, D. H. (1971) · PubMed Central · Cited by 75 · see citing works
Levoamphetamine vs Dextroamphetamine in Minimal Brain Dysfunction
Arnold, L. E. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030012002 · Cited by 75 · see citing works
Self-citationMcNamara, C., Davidson, E. S., & Schenk, S. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90532-x · Cited by 68 · see citing works
Arnold, L. E., Kirilcuk, V., Corson, S. A., et al. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.2.165 · Cited by 66 · see citing works
Self-citationDextroamphetamine and Methylphenidate in the Treatment of Hyperactive/Aggressive Children
Winsberg, B. G., Press, M., Bialer, I., & Kupietz, S. S. (1974) · PEDIATRICS · doi:10.1542/peds.53.2.236 · Cited by 65 · see citing works
Psychological Effects of Stimulant Drugs in Children with Minimal Brain Dysfunction.
Conners, C. K. (1972) · PEDIATRICS · Cited by 61 · see citing works
Little, K. Y., Kirkman, J. A., Carroll, F. I., Breese, G. R., & Duncan, G. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07435.x · Cited by 58 · see citing works
During, M. J., Bean, A. J., & Roth, R. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90698-7 · Cited by 56 · see citing works
Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation.
Holtzman, S. G. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23335-3 · Cited by 52 · see citing works
Finn, I. B., Iuvone, P. M., & Holtzman, S. G. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90023-k · Cited by 45 · see citing works
Héron, C., Costentin, J., & Bonnet, J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00502-8 · Cited by 42 · see citing works
Zaczek, R. C., Battaglia, G., Contrera, J. F., Culp, S. G., & Souza, E. B. D. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90309-8 · Cited by 41 · see citing works
Influence of naloxone upon motor activity induced by psychomotor stimulant drugs
Jones, D. N. C., & Holtzman, S. G. (1994) · Psychopharmacology · doi:10.1007/bf02244839 · Cited by 36 · see citing works
d-Amphetamine versus methylphenidate effects in depressed inpatients.
Little, K. Y. (1993) · PubMed · Cited by 35 · see citing works
Rosen, J. B., Young, A. M., Beuthin, F. C., et al. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90340-0 · Cited by 26 · see citing works
Amphetamine, but Not Methylphenidate, Predicts Antidepressant Efficacy
Little, K. Y. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198806000-00004 · Cited by 24 · see citing works
Sershen, H. W. (1988) · Neuropharmacology · doi:10.1016/0028-3908(88)90196-7 · Cited by 19 · see citing works
Barkley, R. A., DuPaul, G. J., & Costello, A. J. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2884-5_8 · Cited by 16 · see citing works
Arnold, L. E. (1973) · JAMA · doi:10.1001/jama.1973.03220110051016 · Cited by 14 · see citing works
Self-citationAmphetamine, but Not Methylphenidate, Predicts Antidepressant Response
Gwirtsman, H. E., & Guzé, B. H. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198912000-00026 · Cited by 12 · see citing works
Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviors
Moss, D. E., Koob, G. F., McMaster, S. B., et al. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(84)80050-7 · Cited by 9 · see citing works
Logan, L., Seale, T. W., Cao, W., et al. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90247-x · Cited by 9 · see citing works
Glavin, G. B. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90009-7 · Cited by 8 · see citing works
Treatment of 'minimal brain dysfunction'.
Abbie, M. (1974) · PubMed · Cited by 6 · see citing works
Arnold, L. E., Huestis, R. D., Wemmer, D., et al. (1978) · Journal of Learning Disabilities · doi:10.1177/002221947801100303 · Cited by 5 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Aman, M.G., & Rojahn, J. (1990). Pharmacological intervention. In N.N. Singh & I.L. Beale (Eds.), Current perspectives in learning disabilities: Nature, theory, and treatment. New York: Springer-Verlag.
- Grcevich, S, Rowane, W.A, Marcellino, B, & Sullivan-Hurst, S. (1999). Adderall vs. methylphenidate in children with attention-deficit/hyperactivity disorder. Poster at ChADD (Children and Adults with Attention-Deficit Disorder) 11th International Conference on Attention-Deficit/Hyperactivity disorder, Washington, DC, October 7, 1999.
Cited by
Sorted by citations
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765 · see citing works
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927 · see citing works
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
Faraone, S. V., & Buitelaar, J. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0054-3 · Cited by 485 · see citing works
Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
Cortese, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1917069 · Cited by 342 · see citing works
Molina, B. S. G., Hinshaw, S. P., Eugene Arnold, L., Swanson, J. M., Pelham, W. E., Hechtman, L., Hoza, B., Epstein, J. N., Wigal, T., Abikoff, H. B., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.014 · Cited by 246 · see citing works
VITIELLO, B., SEVERE, J. B., GREENHILL, L. L., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., ELLIOTT, G. R., HECHTMAN, L., JENSEN, P. S., HINSHAW, S. P., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00013 · Cited by 163 · see citing works
Self-citationHodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0286-5 · Cited by 147 · see citing works
Handen, B. L., Aman, M. G., Arnold, L. E., Hyman, S. L., Tumuluru, R. V., Lecavalier, L., Corbett-Dick, P., Pan, X., Hollway, J. A., Buchan-Page, K. A., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.08.013 · Cited by 147 · see citing works
Self-citationthe 311 Study Group, Wigal, S. B., Kollins, S. H., Childress, A. C., & Squires, L. (2009) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-3-17 · Cited by 112 · see citing works
Faraone, S. V., Biederman, J., & Roe, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200210000-00005 · Cited by 91 · see citing works
López, F. A., & Leroux, J. R. (2013) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-013-0106-x · Cited by 43 · see citing works
Najib, J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.01.015 · Cited by 40 · see citing works
Denchev, P., Kaltman, J. R., Schoenbaum, M., & Vitiello, B. (2010) · Circulation · doi:10.1161/circulationaha.109.901256 · Cited by 38 · see citing works
Moen, M. D., & Keam, S. J. (2009) · CNS Drugs · doi:10.2165/11201140-000000000-00000 · Cited by 27 · see citing works
Jain, R., Babcock, T., Burtea, T., Dirks, B., Adeyi, B., Scheckner, B., & Lasser, R. (2011) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-5-35 · Cited by 26 · see citing works
Jain, R., Babcock, T., Burtea, T., Dirks, B., Adeyi, B., Scheckner, B., Lasser, R., Renna, J., & Duncan, D. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0027-2 · Cited by 9 · see citing works
- Authors
- Arnold, L. E.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Arnold, L. E.
- ORCID
- Arnold, L. E.
- Venue
- Journal of Attention Disorders
- Publisher
- SAGE Publications
- Published
- 2000-01
- Volume
- 3
- Issue
- 4
- Pages
- 200-211
- ISSN
- 1087-0547 (ISSN-L)
- 1557-1246
- OpenAlex
- W2162170558
- Cited by
- 164
- References
- 54
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 10 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 6 · 2016: 8 · 2015: 8 · 2014: 13 · 2013: 9 · 2012: 9
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- Journal of Attention Disorders (publishedVersion)
- The Knowledge Bank (The Ohio State University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- methylphenidate, amphetamine, attention deficit hyperactivity disorder, crossover trial, dopamine uptake inhibition, catecholamine release, adverse effects, treatment response, learning disabilities, conduct disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
